NovaBridge Biosciences | Corporate Governance

Corporate Governance Overview

NovaBridge is committed to upholding the highest standards of business ethics and conducts business in accordance with all applicable laws, rules and regulations. Our corporate governance policies are designed to protect the interests of our shareholders and promote responsible business practices and corporate citizenship. To view our Code of Business Conduct and Ethics and other related Corporate Governance documents please refer to the links on this page.

Below is a summary of our committee structure and membership information.

Director Name	Audit Committee	Nominating and Corporate Governance Committee	Compensation Committee	Research and Development Committee	ESG Committee
Fu Wei		Chairperson of the Nominating and Corporate Governance Committee	Chairperson of the Compensation Committee
Sean Fu, PhD, MBA				Member of the Research and Development Committee	Member of the ESG Committee
Emmett T. Cunningham Jr, MD, PhD, MPH				Member of the Research and Development Committee
Chun Kwok Alan Au	Member of the Audit Committee	Member of the Nominating and Corporate Governance Committee	Member of the Compensation Committee		Chairperson of the ESG Committee
Sean Cao, PhD				Member of the Research and Development Committee
Robert Lenz, MD, PhD				Chairperson of the Research and Development Committee
Conor Chia-hung Yang	Chairperson of the Audit Committee	Member of the Nominating and Corporate Governance Committee	Member of the Compensation Committee
Xin Liu	Member of the Audit Committee
Ian Woo		Member of the Nominating and Corporate Governance Committee

Fu Wei

Sean Fu, PhD, MBA

Emmett T. Cunningham Jr, MD, PhD, MPH

Chun Kwok Alan Au

Sean Cao, PhD

Robert Lenz, MD, PhD

Conor Chia-hung Yang

Xin Liu

Ian Woo

= Chairperson = Member

Corporate Governance

Corporate Governance Overview

Governance Documents

Governance Charters

Committee Composition